American Cutaneous and Mucocutaneous Leishmaniasis (Tegumentary): A Diagnostic Challenge

Lainson R Shaw JJ . Evolution, classification and geographical distribution. In: Peters W Killick-Kendrick R , eds. The leishmaniasis in biology and medicine. London: Academic Press, 1987:1–120.

Grimaldi G Tesh RB McMahon-Pratt D. A review of the geographic distribution and epidemiology of leishmaniasis in the New World. Am J Trop Med Hyg 1989; 41: 687–725.

Anonymous . Control of the leishmaniasis. Geneva: World Health Organization, Technial Report Series 793, 1990.

e Silva DaRocha EO Capinzaiki AN Kuratomi CA Guedes ACM . A leismanoise tegumentar americana no litorial sul do estado de Sao Paulo. Rev Brasil Malariol D Trop 1980; 32: 9–25.

Scorza JV Valera M deScorza C A new species of Leishmania parasite from the Venezuelan Andes region. Trans R Soc Trop Med Hyg 1979; 73: 293–8.

Corredor A Kreutzer RD Tesh RB Distribution and etiology of leishmaniasis in Colombia. Am J Trop Med Hyg 1990; 42:206–14.

Montoya J Jaramillo C Palma G Gomez T Segura I Travi B. Report of an epidemic outbreak of tegumentary leishmaniasis in a coffee-growing area of Colombia. Mem Inst Oswaldo Cruz, Rio de Janeiro 1990; 85: 119–21.

Blackwell JM . Receptors and recognition mechanisms of Leishmania species. Trans R Soc Trop Med Hyg 1985; 79: 606–12.

Werner JK Barreto P. Leishmaniasis in Colombia, a review. Am J Trop Med Hyg 1981; 30: 751–61.

Jones TC Johnson WD Barreto AC Epidemiology of American cutaneous leishmaniasis due to Leishmania braziliensis braziliensis. J Infect Dis 1987; 156: 73–83.

Weigle KA Saravia NG Davalos M Moreno LH D'Alessandro A. Leishmania braziliensis from the pacific coast region of Colombia: Foci of transmission. Clinical spectrum and isoenzyme phenotypes. Am J Trop Med Hyg 1986; 35:722–31.

Restrepo M. La reaccion de Montenegro en la epidemiologia de la leishmaniasis sudamericana. Bol Of Sanit Pan 1980; 89: 130.

Loyola E. Epidemiologia de la leishmaniasis mucocutanea en el foco natural del Bajo Calima, Buenaventura. Thesis 1985; Universidad del Valle, Cali, Colombia.

Gutierrez Y Salinas GH Palma G Valderrama LB Santrich CV Saravia NG . Correlation between histopathology, immune response, clinical presentation, and evolution in Leishmania braziliensis infection. Am J Trop Med Hyg 1991; 45: 281–9.

Santrich C Segura I Arias AL Saravia NG . Mucosal disease caused by Leishmania braziliensis guyanensis. Am J Trop Med Hyg 1990; 42: 51–5.

Saravia NG Weigle K Segura I Recurrent lesions in human Leishmania braziliensis infection — reactivation or reinfection? Lancet 1990;336:398–402.

Velasco O Savarino SJ Walton BC Gam AA Neva FA . Diffuse cutaneous leishmaniasis in Mexico. Am J Trop Med Hyg 1989; 41: 280–8.

Convit J Pinardi ME Rondon AJ . Diffuse cutaneous leishmaniasis: A disease due to an immunological defect of the host. Trans R Soc Trop Med Hyg 1972; 66: 603–10.

El-Safi SH Peters W Evans DA . Studies on the leishmaniases in the Sudan. 3. Clinical and parasitological studies on visceral and mucosal leishmaniasis. Trans R Soc Trop Med Hyg 1991; 85: 465–70.

Nicodemo EL Duarte MIS Corbett CEP Visceral leishmaniasis in aids patient. Correspondence. Rev Inst Med Trop Sao Paulo 1990; 32: 310–11.

Montalban C Martinez-Fernandez R Calleja JL Visceral leishmaniasis (Kala-azar) as an opportunistic infection in patients infected with the human immunodeficiency virus in Spain. Rev Infect Dis 1989; 11: 655–60.

Cuba CC Llanos-Cuentas EA Barreto AC Human mucocutaneous leishmaniasis in Tres Bracos, Bahia — Brazil. An area of leishmania braziliensis braziliensis transmission. I. Laboratory diagnosis. Rev Soc Brasil Med Trop 1984; 17: 161–7.

Weigle KA de Davalos M Heredia P Molineros R Saravia NG D'Alessandro A. Diagnosis of cutaneous and mococutaneous leishmaniasis in Colombia: A comparison of seven methods. Am J Trop Med Hyg 1987; 36: 489–96.

Navin TR Arana FE de Merida AM Arana BA Castillo AL Silvers DN . Cutaneous leishmaniasis in Guatemala: Comparison of diagnostic methods. Am J Trop Med Hyg 1990; 42: 36–42.

Anonymous . The Leishmaniasis. Geneva: World Health Organization. Tech Rep Ser No. 701:1984.

Kubba R Al-Gindan Y El-Hassan AM Omer AHS . Clinical diagnosis of cutaneous leishmaniasis (oriental sore). J Am Acad Dermatol 1987; 16: 1183–9.

Cuentas Llanos EA Cuba CC Barreto AC Marsden PD . Clinical characteristics of human Leishmania braziliensis braziliensis infections. Trans R Soc Trop Med Hyg 1984; 78: 845–6.

Mayrink W Williams P Coelho MV Epidemiology of dermal leishmaniasis in the Rio Doce Valley, State of Minas Gerais, Brazil. Ann Trop Med Parasit 1979; 73: 123–37.

Palma G Gutierrez Y. The diagnosis of Leishmania. Clin Lab Med 1991; 11: 909–22.

Salinas G Valderrama L Palma G Montes G Saravia NG . Detección de amastigotas en leishmaniasis cutánea y mucocutánea por el método de inmunoperoxidasa, usando anticuerpo policlonal: Sensibilidad y especificidad comparados con métodos convencionales de diagnóstico. Mem Inst Oswaldo Cruz, Rio de Janeiro 1989; 84: 53–60.

Cuba CA Netto EM Marsden PD de Rosa A C Cuentas Llanos EA Costa JL . Cultivation of Leishmania braziliensis braziliensis from skin ulcers in man under field conditions. Trans R Soc Trop Med Hyg 1986; 80: 456–7.

Senekjie HA . Studies on the culture of Leishmania tropica. Trans R Soc Trop Med Hyg 1939; 33: 267–9.

Shaw JJ Lainson R. The in vitro cultivation of members of the Leishmania braziliensis complex. Trans R Soc Trop Med Hyg 1981; 75: 127.

Hendricks L Wright N. Diagnosis of cutaneous leishmaniasis by in vitro cultivation of saline aspirates in Schneider's drosophila medium. Am J Trop Med Hyg 1979; 28: 962–4.

Weigle KA Valderrama L Arias AL Santrich C Saravia NG . Leishmanin skin test standardization and evaluation of safety, dose, storage, longevity of reaction and sensitization. Am J Trop Med Hyg 1991; 44: 260–71.

Pappas MG McGreevy PB Hajkowski R Hendricks LD Oster CHN Hockmeyer WT . Evaluation of promastigote and amastigote antigens in the indirect fluorescent antibody test for American cutaneous leishmaniasis. Am J Trop Med Hyg 1983; 32: 1260–7.

Sokal JE . Measurement of delayed skin-test responses. N Engl J Med 1975; 293: 501–2.

Saravia NG Valderrama L Labrada M The relationship of leishmania braziliensis subspecies and immune response to disease expression in New World leishmaniasis. J Infect Dis 1989; 159: 725–35.

Celeste BJ Guimaraes MC Corrales EM . Peroxidase antibody test for mucocutaneous leishmaniasis serology. Performance indexes and comparison with a fluorescent antibody test. Rev Inst Med Trop Sao Paulo 1988; 30: 411–14.

Cuba CA Marsden PD Barreto AC Rocha R Sampaio RR Patzlaff L. Diagnostico parasitologico e inmunologico de leishmaniasis tegumentaria americana. Bol Ofi Sanit Panam 1980; 89: 195–208.

Restrepo M Gomez ME . La reaccion de inmunofluorescencia indirecta en el diagnostico de la leishmaniasis tegumentaria americana. Biomedica 1983; 3: 15–21.

Ulrich M Centeno M Mattout Z Convit J. Serological patterns and specificity in American cutaneous leishmaniasis. Am J Trop Med Hyg 1988; 39: 179–84.

Badaro R Reed SG Carvalho EM . Immunofluorescent antibody test in American visceral leishmaniasis: Sensitivity and specificity of different morphological forms of two Leishmania species. Am J Trop Med Hyg 1983; 32: 480–4.

Labrada M Weigle KA Valderrama L Saravia NG . Evaluación de la respuesta de isotipos de inmunoglobulina específica a leishmania en leishmaniasis tegumentaria americana. Mem Inst Oswaldo Cruz, Rio de Janeiro 1989; 84: 409–16.

Barker DC . DNA diagnosis of human leishmaniasis. Parasitol Today 1987; 3: 177–84.

Rodgers MR Popper SJ Wirth DF . Amplification of kinetoplast DNA as a tool in the detection and diagnosis of Leishmania. Exp Parasitol 1990; 71: 267–75.

Gutierrez Y. Diagnostic pathology of parasitic infections with clinical correlations. Philadelphia: Lea & Febiger, 1990:20–54.

Ridley DS Ridley MJ . The evolution of the lesion in cutaneous leishmaniasis. J Pathol 1983; 141: 83–96.

Roberts GD . Subcutaneous mycosis. In: Balows A Hausler WJ , eds. Diagnostic procedures for bacterial, mycotic and parasitic infections. Washington: American Public Health Association, Inc., 1981:931–47.

Saenz RE Paz HM Johnson CM Treatment of american cutaneous leishmaniasis with orally administered allopurinol riboside. J Infect Dis 1989; 160: 153–8.

Marsden PD . Pentavalent antimonials: Old drugs for new diseases. Rev Soc Brasileira Med Trop 1985; 18: 187–98.

Berman JD . Chemotherapy for leishmaniasis: Biochemical mechanisms, clinical efficacy, and future strategies. Rev Infect Dis 1988; 10: 560–86.

Rocha RA Sampaio RN Guerra M Apparent glucantime failure in five patients with mucocutaneous leishmaniasis. J Trop Med Hyg 1980; 83: 131–9.

Convit J Rondon A Ulrich M Immunotherapy versus chemotherapy in localised cutaneous leishmaniasis. Lancet 1987;401–5.

Navin TR Arana BA Arana FE deMerida AM Castillo LA Pozuelos JL . Placebo-controlled clinical trial of meglumine antimonate (glucantime) vs. localized controlled heat in the treatment of cutaneous leishmaniasis in Guatemala. Am J Trop Med Hyg 1990; 42: 43–50.

Ballou RW Gordon DM Andujar J Safety and efficacy of high-dose sodium stibogluconate therapy of American cutaneous leishmaniasis. Lancet 1987;13–16.

Franke ED Wignall SF Cruz ME Efficacy and toxicity of sodium stibogluconate for mucosal leishmaniasis. Ann Inter Med 1990; 113: 934–40.

Kellum RE . Treatment of cutaneous leishmaniasis with an intralesional antimonial drug (Pentostam). J Am Acad Dermatol 1986; 15: 620–2.

Harms G Chehade AK Racz P Effects of intradermal gamma-interferon in cutaneous leishmaniasis. Lancet 1989;1287–92.